Acetyl L-Carnitine

non-nutrient/non-botanicalO-acetyl-L-carnitine

What is it

Acetyl-L-carnitine (ALCAR) is an acetylated form of L-carnitine, an amino-acid-derived compound the body synthesizes from lysine and methionine in the liver, kidneys, and brain. The added acetyl group helps it cross the blood-brain barrier, making it the preferred form for cognitive and neurological applications.

How it works

Like L-carnitine, ALCAR helps transport long-chain fatty acids into mitochondria for oxidation, supporting ATP production in tissues that depend heavily on fat metabolism (heart, skeletal muscle, brain). The acetyl group is its real distinguishing feature: once across the blood-brain barrier, ALCAR donates that acetyl group for the synthesis of acetylcholine, the neurotransmitter critical to memory, attention, and cholinergic neuron function. ALCAR also helps remove toxic compounds from mitochondria and supports mitochondrial biogenesis, which is the basis for its neuroprotective hypothesis in Alzheimer's disease and age-related cognitive decline. Cholinergic neurons degenerate in Alzheimer's, and ALCAR may support both acetylcholine production and mitochondrial resilience in those vulnerable cells. Bioavailability of ALCAR specifically has not been thoroughly characterized, but it is generally assumed to be similar to or somewhat better than free L-carnitine's 14 to 18 percent oral absorption, with the added advantage of better central nervous system penetration.

Evidence for 6 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Diabetic peripheral neuropathy

Grade B

Good evidence

Multiple randomized trials at 1.5 to 3 g/day for 6 to 12 months have shown improvements in nerve conduction, pain scores, and sensory function in adults with diabetic peripheral neuropathy. Among ALCAR's applications, this has the most consistent evidence base outside of treating documented carnitine deficiency.

Mild cognitive impairment and early Alzheimer's disease

Grade C

Moderate evidence

A 2003 meta-analysis of 21 trials in 1,204 adults with mild cognitive impairment or mild Alzheimer's taking 1.5 to 3 g/day ALCAR for 3 to 12 months found improvements in assessment scores and clinician-rated change versus placebo. A 2003 Cochrane Review of 15 trials at 1 to 3 g/day for 12 to 52 weeks showed reduced symptom severity at 12 and 24 weeks, but not 52 weeks, and concluded routine use was not justified. Effects in established dementia remain unclear.

Depressive symptoms

Grade C

Moderate evidence

Small randomized trials and meta-analyses suggest ALCAR at 1 to 3 g/day produces modest reductions in depressive symptoms, with effect sizes comparable to some SSRIs in elderly populations but with fewer side effects. Larger, longer trials are needed to establish ALCAR as a first-line option.

Chronic fatigue and elderly fatigue

Grade C

Moderate evidence

Trials in elderly adults and people with chronic fatigue syndrome have shown reductions in mental and physical fatigue with 2 g/day ALCAR alone or combined with propionyl-L-carnitine. Evidence quality is mixed and study sizes modest.

Male infertility

Grade C

Moderate evidence

Carnitine supplementation (including ALCAR) has been studied for sperm motility and morphology. A 2022 Cochrane Review of 6 trials in 1,089 subfertile men using 1 to 3 g/day carnitine found improvements in sperm parameters at some timepoints but no clear effect on live birth or pregnancy rates.

Peyronie's disease

Grade D

Mixed evidence

Small trials of ALCAR alone or combined with other agents have explored its use in Peyronie's disease (penile curvature from fibrous plaques). Results are preliminary and mixed; not a standard recommendation.

3 commercial forms

Acetyl-L-carnitine HCl

Crosses the blood-brain barrier; the standard form used in cognitive and neuropathy trials.

The most common consumer form, typically in 500 mg or 1,000 mg capsules. Slightly hygroscopic, so look for moisture-resistant packaging.

Acetyl-L-carnitine arginate

ALCAR combined with arginine; theoretical advantages around nitric oxide and vasodilation, but limited direct evidence.

Marketed as enhancing circulation and absorption. Few independent trials confirm a clinical advantage over plain ALCAR.

ALCAR + alpha-lipoic acid stack

No direct absorption conflict; combination targets mitochondrial function.

Often paired in anti-aging and cognitive protocols based on rodent work suggesting synergy on mitochondrial biogenesis. Human evidence for the synergy is thinner than the marketing suggests.

Dosage

There is no RDA. Clinical trials for cognitive and neurological outcomes have used 1.5 to 3 grams per day, typically split into two or three doses. Studies for diabetic peripheral neuropathy commonly use 2 grams per day; depression studies have used 1 to 3 grams per day; chronic fatigue trials around 2 grams per day. Most consumer products provide 500 to 1,000 mg per capsule.

When and how to take it

ALCAR is typically taken on an empty stomach 20 to 30 minutes before breakfast and again midday, because absorption is slightly better without food and because its mild stimulating effect can disrupt sleep if taken late. Split doses (for example, 500 mg morning and 500 mg early afternoon) maintain steadier plasma levels than a single large dose. Avoid taking it within six hours of bedtime if you are sensitive to its alerting effect. Pairing with alpha-lipoic acid is a common stacking strategy for mitochondrial support, with no known absorption conflict.

Food sources

Food	Amount	%DV
Beef steak (3 oz, cooked)	42 to 122 mg carnitine	—
Ground beef (3 oz, cooked)	65 to 74 mg carnitine	—
Whole milk (1 cup)	8 mg carnitine	—
Cod (3 oz, cooked)	3 to 5 mg carnitine	—
Chicken breast (3 oz, cooked)	2 to 4 mg carnitine	—
Cheddar cheese (2 oz)	2 mg carnitine	—

Safety

Acetyl-L-carnitine is generally well tolerated. Side effects at typical doses (1 to 3 g/day) include mild nausea, GI upset, restlessness, insomnia (when taken late in the day), and rarely a fishy body odor from gut bacterial metabolism. Unlike L-carnitine, ALCAR's stimulating quality is more pronounced for many users, which is why it is typically taken earlier in the day. The TMAO concern raised for L-carnitine applies in principle to ALCAR as well, since unabsorbed ALCAR is also metabolized by gut bacteria, though it has been less directly studied. No Tolerable Upper Intake Level has been established. People with seizure disorders may have increased seizure risk and should consult a clinician. Bipolar disorder is a relative contraindication because case reports describe induced mania.

Who should be cautious

People with bipolar disorder (potential mania induction), seizure disorders, hypothyroidism, or established cardiovascular disease should consult a clinician before use. Pregnant and breastfeeding women have limited safety data. Patients already on cholinesterase inhibitors for Alzheimer's should coordinate with their neurologist before adding ALCAR. Anyone with chronic kidney disease should avoid carnitine forms unless guided by their nephrologist.

Interactions

ALCAR shares the carnitine interaction profile: pivalate-conjugated antibiotics deplete carnitine, and anticonvulsants such as valproic acid, phenobarbital, phenytoin, and carbamazepine reduce carnitine levels. Combined use with thyroid hormone has been associated in case reports with reduced thyroid efficacy. Because ALCAR raises acetylcholine, it could theoretically compound the effects of cholinesterase inhibitors (donepezil, rivastigmine, galantamine) used in Alzheimer's, and should not be combined without specialist guidance.

Frequently asked questions

What's the difference between L-carnitine and acetyl-L-carnitine?⌄

Both come from the same compound family. L-carnitine acts mainly in heart and skeletal muscle to shuttle fats into mitochondria. Acetyl-L-carnitine (ALCAR) has an added acetyl group that lets it cross the blood-brain barrier, where it supports acetylcholine production and brain mitochondrial function. ALCAR is preferred for cognitive and neuropathy applications; L-carnitine for cardiovascular and muscular ones.

Does ALCAR really help with focus and memory?⌄

In adults with mild cognitive impairment or early Alzheimer's, 1.5 to 3 g/day showed modest cognitive improvements in older meta-analyses, but later, longer trials were less impressive. In healthy young adults, evidence for nootropic effects is limited and largely anecdotal.

When should I take ALCAR?⌄

Most people take it on an empty stomach in the morning and again at midday. It has a mild alerting effect, so taking it late in the day can disrupt sleep for some users.

Is ALCAR safe long-term?⌄

Trials up to 12 months at 1.5 to 3 g/day have been well tolerated. Long-term data beyond a year are limited. The TMAO concern raised about L-carnitine cardiovascular risk likely applies to ALCAR as well, though less directly studied.

Can I take ALCAR with my Alzheimer's medication?⌄

Coordinate with the prescribing neurologist. ALCAR raises acetylcholine, which is what cholinesterase inhibitors (Aricept, Exelon, Razadyne) also do via a different mechanism. The interaction is not well characterized; do not combine without medical guidance.

Will ALCAR help with energy or workout performance?⌄

Effects on athletic performance are mixed and generally less robust than for L-carnitine (which itself shows mixed results). ALCAR's stimulating quality may help with perceived energy but is unlikely to meaningfully change strength or endurance metrics.

References

NIH ODS: Carnitine Health Professional Fact Sheet — Office of Dietary Supplements link
Wikidata: Acetyl-L-Carnitine — Wikidata link

Track Acetyl L-Carnitine with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.